636 related articles for article (PubMed ID: 30874782)
1. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
[TBL] [Abstract][Full Text] [Related]
2. Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial.
Lewey J; Wei W; Lauffenburger JC; Makanji S; Chant A; DiGeronimo J; Nanchanatt G; Jan S; Choudhry NK
BMJ Open; 2017 Oct; 7(10):e016551. PubMed ID: 29084790
[TBL] [Abstract][Full Text] [Related]
3. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
[TBL] [Abstract][Full Text] [Related]
4. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
[TBL] [Abstract][Full Text] [Related]
5. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial.
Lauffenburger JC; Ghazinouri R; Jan S; Makanji S; Ferro CA; Lewey J; Wittbrodt E; Lee J; Haff N; Fontanet CP; Choudhry NK
PLoS One; 2019; 14(4):e0214754. PubMed ID: 30939143
[TBL] [Abstract][Full Text] [Related]
6. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
[TBL] [Abstract][Full Text] [Related]
7. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
8. Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Nayak A; Vakili S; Nayak K; Nikolov M; Chiu M; Sosseinheimer P; Talamantes S; Testa S; Palanisamy S; Giri V; Schulman K
JAMA Netw Open; 2023 Dec; 6(12):e2340232. PubMed ID: 38039007
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
[TBL] [Abstract][Full Text] [Related]
10. Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Wong CA; Miller VA; Murphy K; Small D; Ford CA; Willi SM; Feingold J; Morris A; Ha YP; Zhu J; Wang W; Patel MS
JAMA Pediatr; 2017 Dec; 171(12):1176-1183. PubMed ID: 29059263
[TBL] [Abstract][Full Text] [Related]
11. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Johansen MY; MacDonald CS; Hansen KB; Karstoft K; Christensen R; Pedersen M; Hansen LS; Zacho M; Wedell-Neergaard AS; Nielsen ST; Iepsen UW; Langberg H; Vaag AA; Pedersen BK; Ried-Larsen M
JAMA; 2017 Aug; 318(7):637-646. PubMed ID: 28810024
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial.
Kahkoska AR; Lawson MT; Crandell J; Driscoll KA; Kichler JC; Seid M; Maahs DM; Kosorok MR; Mayer-Davis EJ
JAMA Netw Open; 2019 May; 2(5):e195137. PubMed ID: 31150087
[TBL] [Abstract][Full Text] [Related]
13. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
[TBL] [Abstract][Full Text] [Related]
14. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
[TBL] [Abstract][Full Text] [Related]
15. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a Community-Based Structured Physical Activity Program for Adults With Type 2 Diabetes: A Randomized Clinical Trial.
Mukherji AB; Lu D; Qin F; Hedlin H; Johannsen NM; Chung S; Kobayashi Y; Haddad F; Lamendola C; Basina M; Talamoa R; Myers J; Palaniappan L
JAMA Netw Open; 2022 Dec; 5(12):e2247858. PubMed ID: 36542382
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
Luo J; Khan NF; Manetti T; Rose J; Kaloghlian A; Gadhe B; Jain SH; Gagne JJ; Kesselheim AS
JAMA; 2019 Jan; 321(4):374-384. PubMed ID: 30694321
[TBL] [Abstract][Full Text] [Related]
18. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Group Medical Visits Combined With Intensive Weight Management vs Group Medical Visits Alone for Glycemia in Patients With Type 2 Diabetes: A Noninferiority Randomized Clinical Trial.
Yancy WS; Crowley MJ; Dar MS; Coffman CJ; Jeffreys AS; Maciejewski ML; Voils CI; Bradley AB; Edelman D
JAMA Intern Med; 2020 Jan; 180(1):70-79. PubMed ID: 31682682
[TBL] [Abstract][Full Text] [Related]
20. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.
Wright EE; Malone DC; Trujillo JM; Gill J; Huse S; Li X; Zhou FL; Preblick R; Reid T
J Manag Care Spec Pharm; 2022 Jun; 28(6):592-603. PubMed ID: 35352995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
